Growth Metrics

Armata Pharmaceuticals, Inc. (ARMP) Total Current Liabilities (2016 - 2018)

Armata Pharmaceuticals' Total Current Liabilities history spans 6 years, with the latest figure at $2.5 million for Q3 2018.

  • For Q3 2018, Total Current Liabilities changed 0.48% year-over-year to $2.5 million; the TTM value through Sep 2018 reached $2.5 million, changed 0.48%, while the annual FY2017 figure was $2.0 million, 44.38% down from the prior year.
  • Total Current Liabilities for Q3 2018 was $2.5 million at Armata Pharmaceuticals, up from $2.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.7 million in Q2 2017 and bottomed at $1.0 million in Q1 2014.
  • The 5-year median for Total Current Liabilities is $2.4 million (2015), against an average of $2.4 million.
  • The largest annual shift saw Total Current Liabilities soared 106.82% in 2015 before it tumbled 44.79% in 2018.
  • A 5-year view of Total Current Liabilities shows it stood at $1.9 million in 2014, then increased by 20.93% to $2.3 million in 2015, then surged by 56.62% to $3.5 million in 2016, then crashed by 44.38% to $2.0 million in 2017, then rose by 25.25% to $2.5 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Total Current Liabilities are $2.5 million (Q3 2018), $2.0 million (Q2 2018), and $1.8 million (Q1 2018).